News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
501,340 Results
Type
Article (11029)
Company Profile (158)
Press Release (490059)
Multimedia
Podcasts (17)
Webinars (7)
Section
Business (172078)
Career Advice (378)
Deals (26430)
Drug Delivery (15)
Drug Development (55581)
Employer Resources (22)
FDA (10092)
Job Trends (9055)
News (246226)
Policy (18626)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (693)
Accelerated approval (21)
ADA (21)
Adcomms (1)
Allergies (101)
Alliances (34705)
ALS (110)
Alzheimer's disease (1029)
Antibody-drug conjugate (ADC) (310)
Approvals (10661)
Artificial intelligence (352)
ASCO (174)
Autoimmune disease (212)
Automation (32)
Bankruptcy (269)
Best Places to Work (7239)
BIO (41)
BIOSECURE Act (3)
Biosimilars (125)
Biotechnology (101)
Bladder cancer (152)
Brain cancer (33)
Breast cancer (531)
Cancer (3842)
Cardiovascular disease (224)
Career advice (305)
Career pathing (3)
CAR-T (192)
CDC (2)
Celiac Disease (1)
Cell therapy (532)
Cervical cancer (38)
Clinical research (49771)
Collaboration (1348)
Commercialization (1)
Company closure (3)
Compensation (1408)
Complete response letters (38)
COVID-19 (1082)
CRISPR (73)
C-suite (799)
Cystic fibrosis (92)
Data (5828)
Denatured (10)
Depression (113)
Dermatology (61)
Diabetes (355)
Diagnostics (4333)
Digital health (37)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (185)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (179)
Earnings (73928)
Editorial (6)
Employer branding (3)
Employer resources (22)
Events (89743)
Executive appointments (740)
FDA (12712)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (25)
Funding (1056)
Gene editing (150)
Generative AI (13)
Gene therapy (367)
GLP-1 (347)
Government (1134)
Grass and pollen (2)
Guidances (289)
Healthcare (9727)
Hematology (95)
HIV (63)
Huntington's disease (24)
IgA nephropathy (63)
Immunology and inflammation (132)
Immuno-oncology (72)
Indications (153)
Infectious disease (1304)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (92)
Intellectual property (261)
Interviews (47)
IPO (12635)
IRA (7)
Job creations (2150)
Job search strategy (288)
JPM (5)
Kidney cancer (19)
Labor market (13)
Layoffs (108)
Leadership (4)
Legal (5298)
Liver cancer (50)
Longevity (18)
Lung cancer (519)
Lymphoma (255)
Machine learning (30)
Management (9)
Manufacturing (566)
Marketing (7)
MASH (122)
Medical device (8796)
Medtech (8921)
Mergers & acquisitions (14811)
Metabolic disorders (751)
mRNA (67)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (241)
Neuropsychiatric disorders (49)
Neuroscience (1930)
NextGen: Class of 2026 (3381)
Non-profit (1005)
Now hiring (15)
Obesity (249)
Opinion (36)
Ovarian cancer (162)
Pain (175)
Pancreatic cancer (212)
Parkinson's disease (211)
Partnered (14)
Patents (480)
Patient recruitment (508)
Peanut (32)
People (42949)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (16218)
Phase 2 (22337)
Phase 3 (15057)
Pipeline (6991)
Policy (36)
Postmarket research (1607)
Preclinical (6891)
Press Release (35)
Prostate cancer (192)
Psychedelics (13)
Radiopharmaceuticals (199)
Rare diseases (620)
Real estate (3283)
Recruiting (10)
Regulatory (15313)
Reports (21)
Research institute (767)
Resumes & cover letters (54)
Rett syndrome (39)
RNA editing (9)
RSV (51)
Schizophrenia (110)
Series A (189)
Series B (140)
Service/supplier (4)
Sickle cell disease (65)
Special edition (4)
Spinal muscular atrophy (88)
Sponsored (6)
Startups (2313)
Stomach cancer (5)
Supply chain (51)
Tariffs (2)
The Weekly (7)
Vaccines (418)
Venture capital (38)
Weight loss (98)
Women's health (79)
Worklife (1)
Date
Today (75)
Last 7 days (289)
Last 30 days (1204)
Last 365 days (20156)
2026 (11460)
2025 (20301)
2024 (23930)
2023 (27566)
2022 (35972)
2021 (38798)
2020 (35125)
2019 (24431)
2018 (18439)
2017 (19621)
2016 (18797)
2015 (25135)
2014 (22315)
2013 (18744)
2012 (20833)
2011 (20981)
2010 (20800)
Location
Africa (263)
Alabama (75)
Alaska (3)
Arizona (299)
Arkansas (11)
Asia (19453)
Australia (2403)
California (11918)
Canada (3145)
China (580)
Colorado (472)
Connecticut (401)
Delaware (212)
Europe (28814)
Florida (1754)
Georgia (366)
Hawaii (4)
Idaho (47)
Illinois (707)
India (44)
Indiana (318)
Iowa (13)
Japan (397)
Kansas (109)
Kentucky (31)
Louisiana (28)
Maine (25)
Maryland (1187)
Massachusetts (7868)
Michigan (304)
Minnesota (568)
Mississippi (5)
Missouri (84)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (63)
New Jersey (2640)
New Mexico (14)
New York (2778)
North Carolina (1263)
North Dakota (4)
Northern California (5958)
Ohio (284)
Oklahoma (15)
Oregon (17)
Pennsylvania (2233)
Puerto Rico (21)
Rhode Island (31)
South America (438)
South Carolina (75)
South Dakota (1)
Southern California (4900)
Tennessee (120)
Texas (1910)
United States (38688)
Utah (351)
Vermont (1)
Virginia (152)
Washington D.C. (41)
Washington State (957)
West Virginia (2)
Wisconsin (86)
501,340 Results for "replicate bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Replicate Bioscience Awarded Grant to Advance srRNA Vaccine Candidates for Tuberculosis
June 19, 2026
·
3 min read
Press Releases
Replicate Bioscience and Instituto Butantan Enter Collaborative Agreement to Develop and Commercialize Replicate’s Self-Replicating RNA (srRNA) Rabies Vaccine in Latin America
December 4, 2025
·
5 min read
Press Releases
Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer
December 16, 2025
·
3 min read
Press Releases
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria
January 8, 2026
·
4 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
June 12, 2026
·
9 min read
Press Releases
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
June 15, 2026
·
9 min read
Biotech Beach
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
Replicate Bioscience will be participating in the following upcoming investor meetings.
March 1, 2024
·
2 min read
Press Releases
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
July 13, 2026
·
6 min read
Press Releases
Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
July 22, 2026
·
6 min read
1 of 50,134
Next
